Nonclinical regulatory immunotoxicity testing of nanomedicinal products: Proposed strategy and possible pitfalls

Various nanomedicinal products (NMPs) have been reported to induce an adverse immune response, which may be related to their tendency to accumulate in or target cells of the immune system. Therefore, before their market authorization, NMPs should be thoroughly evaluated for their immunotoxic potenti...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology 2020-09, Vol.12 (5), p.e1633-n/a
Hauptverfasser:	Giannakou, Christina, Park, Margriet V. D. Z., Bosselaers, Irene E. M., Jong, Wim H., Laan, Jan Willem, Loveren, Henk, Vandebriel, Rob J., Geertsma, Robert E.
Format:	Artikel
Sprache:	eng
Schlagworte:	Advanced Review Advanced Reviews Biocompatibility Complement activation Evaluation Humans Hypersensitivity ICH‐S8 Immune response Immune system Immune System - drug effects Immune System - immunology Immunosuppression Immunotoxicity in vitro In vivo methods and tests Nanomaterials nanomedicinal product Nanomedicine - legislation & jurisprudence Nanomedicine - standards Nanostructures - adverse effects Nanostructures - standards Nanostructures - toxicity Nanotechnology Pharmaceuticals Pharmacokinetics regulatory Regulatory and Policy Issues in Nanomedicine Risk Assessment Strategy Toxicity Toxicity Tests Toxicology Toxicology of Nanomaterials
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!